BD2Decide leveraging RARECARENet data

  • 22 May

BD2Decide uses data coming from population-based cancer registries contributing to the RARECARENet high resolution study. RARECARENet is a project funded by the Consumers, Health, Agriculture and Food Executive Agency (Chafea) of the European Commission (formerly known as the Executive Agency for Health and Consumers, EAHC). Moreover, BD2Decide team members Lisa Licitra, Gemma Gatta,...


New research project spun-off from BD2Decide work

  • 23 February

The Italian Association for Cancer Research (AIRC) has recently founded the proposal entitled “Radiogenomics Framework for Non-Invasive Personalized Medicine in Head and Neck Cancer” by Loris De Cecco, BD2Decide team member from Partner INT. The project, arising from BD2decide, will validate both the genomic subtype stratification and the signatures in response to EGFR-inhibitors, previously...


Third Consortium Meeting (Parma, 9-10 November 2016)

  • 30 November

On November 9th and 10th, in Parma, at AOP premises, the Third Consortium Meeting was held to discuss the advancement of the Project and outline prospects for the near future. In particular, the Meeting included: a User workshop, to finalize eCRFs, discuss I/F mockups, discuss the patient codecision tool, review the status of patients' data and of clinical study execution a...


BD2Decide data management architecture is now published

  • 31 October

Deliverable D5.1 Multilayer data acquisition and management services addresses the specific multiscale and multivariable data management architecture, on top of which the BD2Decide big data and prognostic modelling techniques will be implemented, with the ultimate aim to improve the decision making process in the treatment of Head and Neck cancer. The involved datasets are presented in four...


UNIPR organized a workshop to discuss BD2Decide with physicians, researchers and patients

  • 07 October

Partner UNIPR, jointly with the University Hospital of Parma, organized a workshop to present to physicians, researchers and patients in Italy, the results of its research projects on cancer, including BD2Decide. The title of the workshop, that took place on September 30th, 2016 in Parma, was: "La ricerca scientifica spiegata ai pazienti. Nuove frontiere terapeutiche nella cura dei tumori...


Second Consortium Meeting (Amsterdam, 9-10 June 2016): BD2Decide is moving on

  • 01 August

On June 9th and 10th, in Amsterdam, at VU/VUmc premises, the Second Consortium Meeting was held to discuss the advancement of the work during the first semester and to plan for the next period. In particular, the discussion included: agreement on the overall platform design and interactions between technical components verify the advances of the clinical study and patients enrolment...


BD2Decide has published its User needs and use cases document

  • 12 July

BD2Decide has published deliverable “D2.1 User needs and use cases”, that presents the user needs and requirements for the Project’s technical and scientific infrastructure. The document, which downloadable from the Downloads page, is a great opportunity to discover in more detail the overall rationale of the Project and to understand what are the most innovative approaches that will be...